Gesundheit
Branchen-Index
Pharmazeutische Erzeugnisse-Aktien
Vollständige Übersicht aller 265 börsennotierten Unternehmen der Branche Pharmazeutische Erzeugnisse. Vergleichen Sie Marktkapitalisierung, Bewertungs-KGV, Dividendenrendite und Insider-Scores im direkten Wettbewerbsvergleich.
Unternehmen
265
100 % erfasst
Gesamtkapitalisierung
5,77 Bio. $
Gesamtwert
Median-KGV
19,8
Bewertungsniveau
Ø Insider-Score
44,8
Conviction-Skala 0–100
| # | Unternehmen / Ticker | Marktkapitalisierung | Letzter Kurs | KGV | Dividende | Insider-Score | Analyse |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & Co | 1,01 Bio. $ Mega Cap | 1.123,00 $ | 49,0 | 0,5 % | 67 | Details › |
| 2 | JNJ JOHNSON & JOHNSON | 653,8 Mrd. $ Mega Cap | 266,35 $ | 24,4 | 0,4 % | 40 | Details › |
| 3 | ONC BeOne Medicines Ltd. | 506,5 Mrd. $ Mega Cap | 341,80 $ | 1.849,9 | — | 40 | Details › |
| 4 | ABBV AbbVie Inc. | 441,1 Mrd. $ Mega Cap | 255,00 $ | 105,4 | 2,7 % | 54 | Details › |
| 5 | MRK Merck & Co., Inc. | 372,2 Mrd. $ Mega Cap | 144,71 $ | 20,4 | 2,2 % | 57 | Details › |
| 6 | NVS NOVARTIS AG | 262,0 Mrd. $ Mega Cap | 137,48 $ | — | 2,9 % | 48 | Details › |
| 7 | AZN ASTRAZENECA PLC | 248,1 Mrd. $ Mega Cap | 159,64 $ | — | 1,8 % | — | Details › |
| 8 | AMGN AMGEN INC | 211,8 Mrd. $ Mega Cap | 382,47 $ | 27,6 | 2,5 % | 58 | Details › |
| 9 | NVO NOVO NORDISK A S | 196,0 Mrd. $ Mega Cap | 44,01 $ | — | 3,6 % | — | Details › |
| 10 | GILD GILEAD SCIENCES, INC. | 182,0 Mrd. $ Mega Cap | 144,81 $ | 21,6 | 2,2 % | 56 | Details › |
| 11 | PFE PFIZER INC | 158,8 Mrd. $ Mega Cap | 27,65 $ | 20,4 | 6,2 % | 47 | Details › |
| 12 | VRTX VERTEX PHARMACEUTICALS INC / MA | 134,3 Mrd. $ Mega Cap | 514,56 $ | 34,5 | — | 64 | Details › |
| 13 | BMY BRISTOL MYERS SQUIBB CO | 131,9 Mrd. $ Mega Cap | 63,75 $ | 18,7 | 3,9 % | 73 | Details › |
| 14 | CSLLY CSL LTD | 116,7 Mrd. $ Mega Cap | 30,16 $ | — | 3,7 % | 23 | Details › |
| 15 | GSK GSK plc | 96,5 Mrd. $ Mega Cap | 48,12 $ | — | 3,4 % | 41 | Details › |
| 16 | REGN REGENERON PHARMACEUTICALS, INC. | 73,5 Mrd. $ Mega Cap | 793,26 $ | 19,5 | — | 53 | Details › |
| 17 | ARGX ARGENX SE | 61,2 Mrd. $ Mega Cap | 984,04 $ | — | — | 62 | Details › |
| 18 | TAK TAKEDA PHARMACEUTICAL CO LTD | 57,7 Mrd. $ Mega Cap | 18,11 $ | — | 3,4 % | 61 | Details › |
| 19 | MRNA Moderna, Inc. | 55,3 Mrd. $ Mega Cap | 136,62 $ | — | — | 32 | Details › |
| 20 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 42,8 Mrd. $ Mega Cap | 36,35 $ | 30,4 | — | 57 | Details › |
| 21 | HLN Haleon plc | 40,4 Mrd. $ Mega Cap | 9,22 $ | — | 1,8 % | 46 | Details › |
| 22 | KVUE Kenvue Inc. | 35,2 Mrd. $ Mega Cap | 17,79 $ | 24,2 | 4,5 % | 59 | Details › |
| 23 | ALNY ALNYLAM PHARMACEUTICALS, INC. | 34,4 Mrd. $ Mega Cap | 247,51 $ | 111,6 | — | 66 | Details › |
| 24 | ZTS Zoetis Inc. | 31,3 Mrd. $ Mega Cap | 72,86 $ | 12,2 | 2,8 % | 74 | Details › |
| 25 | BIIB BIOGEN INC. | 31,2 Mrd. $ Mega Cap | 215,43 $ | 24,2 | — | 71 | Details › |
| 26 | ZLAB Zai Lab Ltd | 28,1 Mrd. $ Mega Cap | 24,17 $ | — | — | 27 | Details › |
| 27 | INSM INSMED Inc | 26,8 Mrd. $ Mega Cap | 127,28 $ | — | — | 49 | Details › |
| 28 | FUJIY FUJI PHOTO FILM CO LTD /FI | 24,8 Mrd. $ Mega Cap | 10,37 $ | — | 2,5 % | — | Details › |
| 29 | INCY INCYTE CORP | 24,7 Mrd. $ Mega Cap | 123,28 $ | 19,4 | — | 63 | Details › |
| 30 | UTHR UNITED THERAPEUTICS Corp | 21,7 Mrd. $ Mega Cap | 503,86 $ | 17,9 | — | 73 | Details › |
| 31 | VTRS Viatris Inc | 20,0 Mrd. $ Mega Cap | 16,38 $ | — | 0,7 % | 56 | Details › |
| 32 | ASND Ascendis Pharma A/S | 16,1 Mrd. $ Mega Cap | 261,23 $ | — | — | — | Details › |
| 33 | NBIX NEUROCRINE BIOSCIENCES INC | 15,5 Mrd. $ Mega Cap | 156,57 $ | 33,2 | — | 65 | Details › |
| 34 | EXEL EXELIXIS, INC. | 15,1 Mrd. $ Mega Cap | 57,43 $ | 20,7 | — | 63 | Details › |
| 35 | JAZZ Jazz Pharmaceuticals plc | 14,7 Mrd. $ Mega Cap | 240,48 $ | — | — | 50 | Details › |
| 36 | SMMT Summit Therapeutics Inc. | 13,4 Mrd. $ Mega Cap | 17,00 $ | — | — | 43 | Details › |
| 37 | BMRN BIOMARIN PHARMACEUTICAL INC | 12,4 Mrd. $ Mega Cap | 65,51 $ | 35,9 | — | 53 | Details › |
| 38 | MDGL MADRIGAL PHARMACEUTICALS, INC. | 12,2 Mrd. $ Mega Cap | 533,12 $ | — | — | 35 | Details › |
| 39 | CORT CORCEPT THERAPEUTICS INC | 12,1 Mrd. $ Mega Cap | 114,92 $ | 139,0 | — | 29 | Details › |
| 40 | ELAN Elanco Animal Health Inc | 11,9 Mrd. $ Mega Cap | 22,86 $ | — | — | 28 | Details › |
| 41 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | 11,5 Mrd. $ Mega Cap | 82,76 $ | — | — | 63 | Details › |
| 42 | RDY DR REDDYS LABORATORIES LTD | 9,8 Mrd. $ Large Cap | 11,71 $ | — | 0,7 % | 54 | Details › |
| 43 | CYTK CYTOKINETICS INC | 9,3 Mrd. $ Large Cap | 73,62 $ | — | — | 28 | Details › |
| 44 | IONS IONIS PHARMACEUTICALS INC | 9,3 Mrd. $ Large Cap | 55,65 $ | — | — | 31 | Details › |
| 45 | TGTX TG THERAPEUTICS, INC. | 8,7 Mrd. $ Large Cap | 55,39 $ | 20,1 | — | 60 | Details › |
| 46 | GPCR Structure Therapeutics Inc. | 8,6 Mrd. $ Large Cap | 39,55 $ | — | — | 51 | Details › |
| 47 | ABVX Abivax S.A. | 8,4 Mrd. $ Large Cap | 115,95 $ | — | — | 36 | Details › |
| 48 | CRNX Crinetics Pharmaceuticals, Inc. | 8,1 Mrd. $ Large Cap | 84,95 $ | — | — | 60 | Details › |
| 49 | IMVT Immunovant, Inc. | 8,1 Mrd. $ Large Cap | 38,10 $ | — | — | 51 | Details › |
| 50 | ALKS Alkermes plc. | 7,5 Mrd. $ Large Cap | 46,11 $ | 31,8 | — | 65 | Details › |
| 51 | BLTE BELITE BIO, INC | 7,0 Mrd. $ Large Cap | 175,07 $ | — | — | 54 | Details › |
| 52 | RYTM RHYTHM PHARMACEUTICALS, INC. | 6,8 Mrd. $ Large Cap | 102,20 $ | — | — | 29 | Details › |
| 53 | GRFS Grifols SA | 6,5 Mrd. $ Large Cap | 7,65 $ | — | 2,3 % | 49 | Details › |
| 54 | LNTH Lantheus Holdings, Inc. | 6,5 Mrd. $ Large Cap | 100,39 $ | 29,5 | — | 40 | Details › |
| 55 | KNSA Kiniksa Pharmaceuticals International, plc | 6,1 Mrd. $ Large Cap | 76,48 $ | 102,8 | — | 58 | Details › |
| 56 | TVTX Travere Therapeutics, Inc. | 6,0 Mrd. $ Large Cap | 67,51 $ | — | — | 42 | Details › |
| 57 | AMRN AMARIN CORP PLC\UK | 5,9 Mrd. $ Large Cap | 14,04 $ | — | — | 57 | Details › |
| 58 | LQDA Liquidia Corp | 5,9 Mrd. $ Large Cap | 67,85 $ | — | — | 50 | Details › |
| 59 | LGND LIGAND PHARMACEUTICALS INC | 5,7 Mrd. $ Large Cap | 289,25 $ | 47,1 | 0,9 % | 63 | Details › |
| 60 | PTCT PTC THERAPEUTICS, INC. | 5,6 Mrd. $ Large Cap | 67,37 $ | 8,8 | — | 57 | Details › |
| 61 | AMRX Amneal Pharmaceuticals, Inc. | 5,5 Mrd. $ Large Cap | 16,87 $ | 77,5 | — | 55 | Details › |
| 62 | MIRM Mirum Pharmaceuticals, Inc. | 5,2 Mrd. $ Large Cap | 100,61 $ | — | — | 34 | Details › |
| 63 | ACAD ACADIA PHARMACEUTICALS INC | 4,7 Mrd. $ Large Cap | 27,74 $ | 12,0 | — | 61 | Details › |
| 64 | ERAS Erasca, Inc. | 4,6 Mrd. $ Large Cap | 16,03 $ | — | — | 41 | Details › |
| 65 | INDV Indivior Pharmaceuticals, Inc. | 4,4 Mrd. $ Large Cap | 34,51 $ | 20,9 | — | 45 | Details › |
| 66 | TLX Telix Pharmaceuticals Ltd | 4,0 Mrd. $ Large Cap | 11,90 $ | — | — | 36 | Details › |
| 67 | MANE Veradermics, Inc | 4,0 Mrd. $ Large Cap | 100,35 $ | — | — | 29 | Details › |
| 68 | DFTX Definium Therapeutics, Inc. | 3,8 Mrd. $ Large Cap | 37,73 $ | — | — | 61 | Details › |
| 69 | AMLX Amylyx Pharmaceuticals, Inc. | 3,7 Mrd. $ Large Cap | 32,09 $ | — | — | 60 | Details › |
| 70 | TARS Tarsus Pharmaceuticals, Inc. | 3,7 Mrd. $ Large Cap | 81,12 $ | — | — | 28 | Details › |
| 71 | OGN Organon & Co. | 3,6 Mrd. $ Large Cap | 13,63 $ | 19,1 | 2,5 % | 70 | Details › |
| 72 | IMNM Immunome Inc. | 3,0 Mrd. $ Large Cap | 24,97 $ | — | — | 37 | Details › |
| 73 | ARQT Arcutis Biotherapeutics, Inc. | 3,0 Mrd. $ Large Cap | 23,38 $ | — | — | 39 | Details › |
| 74 | NAMS NewAmsterdam Pharma Co N.V. | 2,9 Mrd. $ Large Cap | 21,86 $ | — | — | 36 | Details › |
| 75 | CUE Cue Biopharma, Inc. | 2,9 Mrd. $ Large Cap | 28,00 $ | — | — | 28 | Details › |
| 76 | ATAI AtaiBeckley Inc. | 2,6 Mrd. $ Large Cap | 7,35 $ | — | — | 40 | Details › |
| 77 | PHVS Pharvaris N.V. | 2,6 Mrd. $ Large Cap | 37,51 $ | — | — | 48 | Details › |
| 78 | OCUL OCULAR THERAPEUTIX, INC | 2,5 Mrd. $ Large Cap | 10,62 $ | — | — | 31 | Details › |
| 79 | SUPN SUPERNUS PHARMACEUTICALS, INC. | 2,4 Mrd. $ Large Cap | 41,69 $ | — | — | 54 | Details › |
| 80 | HRMY Harmony Biosciences Holdings, Inc. | 2,4 Mrd. $ Large Cap | 41,10 $ | 15,5 | — | 59 | Details › |
| 81 | PBH Prestige Consumer Healthcare Inc. | 2,4 Mrd. $ Large Cap | 47,34 $ | 12,7 | — | 59 | Details › |
| 82 | BHC Bausch Health Companies Inc. | 2,4 Mrd. $ Large Cap | 6,07 $ | 15,3 | 19,9 % | 45 | Details › |
| 83 | HCM HUTCHMED (China) Ltd | 2,3 Mrd. $ Large Cap | 13,12 $ | — | — | 62 | Details › |
| 84 | ADMA ADMA BIOLOGICS, INC. | 2,3 Mrd. $ Large Cap | 9,39 $ | 15,9 | — | 55 | Details › |
| 85 | SRPT Sarepta Therapeutics, Inc. | 2,2 Mrd. $ Large Cap | 20,52 $ | — | — | 38 | Details › |
| 86 | TRVI Trevi Therapeutics, Inc. | 2,2 Mrd. $ Large Cap | 15,91 $ | — | — | 29 | Details › |
| 87 | AUPH Aurinia Pharmaceuticals Inc. | 2,1 Mrd. $ Large Cap | 16,11 $ | 7,8 | — | 48 | Details › |
| 88 | URGN UroGen Pharma Ltd. | 2,1 Mrd. $ Large Cap | 42,24 $ | — | — | 47 | Details › |
| 89 | AGIO AGIOS PHARMACEUTICALS, INC. | 2,0 Mrd. $ Mid Cap | 33,64 $ | — | — | 45 | Details › |
| 90 | BCRX BIOCRYST PHARMACEUTICALS INC | 1,9 Mrd. $ Mid Cap | 8,29 $ | 7,5 | — | 72 | Details › |
| 91 | KLRA Kailera Therapeutics, Inc. | 1,9 Mrd. $ Mid Cap | 14,91 $ | — | — | 73 | Details › |
| 92 | PVLA PALVELLA THERAPEUTICS, INC. | 1,9 Mrd. $ Mid Cap | 150,39 $ | — | — | 31 | Details › |
| 93 | NBTX Nanobiotix S.A. | 1,8 Mrd. $ Mid Cap | 37,60 $ | — | — | 33 | Details › |
| 94 | ALVO Alvotech | 1,8 Mrd. $ Mid Cap | 5,24 $ | — | — | 35 | Details › |
| 95 | STOK Stoke Therapeutics, Inc. | 1,8 Mrd. $ Mid Cap | 29,34 $ | — | — | 40 | Details › |
| 96 | SNDX Syndax Pharmaceuticals Inc | 1,7 Mrd. $ Mid Cap | 18,82 $ | — | — | 27 | Details › |
| 97 | NVAX NOVAVAX INC | 1,7 Mrd. $ Mid Cap | 9,30 $ | 3,9 | — | 31 | Details › |
| 98 | QNCX Quince Therapeutics, Inc. | 1,6 Mrd. $ Mid Cap | 28,96 $ | — | — | 22 | Details › |
| 99 | ETON Eton Pharmaceuticals, Inc. | 1,6 Mrd. $ Mid Cap | 57,88 $ | — | — | 50 | Details › |
| 100 | INVA Innoviva, Inc. | 1,6 Mrd. $ Mid Cap | 20,62 $ | 6,5 | — | 74 | Details › |
| 101 | ANIP ANI PHARMACEUTICALS INC | 1,6 Mrd. $ Mid Cap | 71,46 $ | 21,2 | — | 71 | Details › |
| 102 | AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | 1,6 Mrd. $ Mid Cap | 16,67 $ | — | — | 24 | Details › |
| 103 | AVLN Avalyn Pharma Inc. | 1,5 Mrd. $ Mid Cap | 34,71 $ | — | — | — | Details › |
| 104 | RARE Ultragenyx Pharmaceutical Inc. | 1,4 Mrd. $ Mid Cap | 14,40 $ | — | — | 47 | Details › |
| 105 | XERS Xeris Biopharma Holdings, Inc. | 1,4 Mrd. $ Mid Cap | 7,67 $ | — | — | 54 | Details › |
| 106 | HROW HARROW, INC. | 1,4 Mrd. $ Mid Cap | 36,58 $ | — | — | 34 | Details › |
| 107 | VYNE Yarrow Bioscience, Inc. | 1,3 Mrd. $ Mid Cap | 39,50 $ | — | — | — | Details › |
| 108 | CGEM Cullinan Therapeutics, Inc. | 1,3 Mrd. $ Mid Cap | 21,00 $ | — | — | 36 | Details › |
| 109 | AVBP ArriVent BioPharma, Inc. | 1,3 Mrd. $ Mid Cap | 28,70 $ | — | — | 41 | Details › |
| 110 | MNKD MANNKIND CORP | 1,3 Mrd. $ Mid Cap | 3,79 $ | 208,0 | — | 44 | Details › |
| 111 | SPTX Seaport Therapeutics, Inc. | 1,2 Mrd. $ Mid Cap | 23,28 $ | — | — | 45 | Details › |
| 112 | ANRO Alto Neuroscience, Inc. | 1,1 Mrd. $ Mid Cap | 31,68 $ | — | — | 28 | Details › |
| 113 | PAHC PHIBRO ANIMAL HEALTH CORP | 1,1 Mrd. $ Mid Cap | 36,58 $ | 15,1 | 1,3 % | 45 | Details › |
| 114 | SVRA Savara Inc | 1,1 Mrd. $ Mid Cap | 5,32 $ | — | — | 65 | Details › |
| 115 | KURA Kura Oncology, Inc. | 1,1 Mrd. $ Mid Cap | 11,57 $ | — | — | 45 | Details › |
| 116 | PCRX Pacira BioSciences, Inc. | 1,1 Mrd. $ Mid Cap | 25,16 $ | 161,7 | — | 51 | Details › |
| 117 | AMPH Amphastar Pharmaceuticals, Inc. | 1,0 Mrd. $ Mid Cap | 23,54 $ | 11,3 | — | 63 | Details › |
| 118 | CRVS Corvus Pharmaceuticals, Inc. | 1,0 Mrd. $ Mid Cap | 12,94 $ | — | — | 48 | Details › |
| 119 | GERN GERON CORP | 966,2 Mio. $ Mid Cap | 1,37 $ | — | — | 22 | Details › |
| 120 | GLUE Monte Rosa Therapeutics, Inc. | 935,3 Mio. $ Mid Cap | 14,32 $ | — | — | 27 | Details › |
| 121 | TBPH Theravance Biopharma, Inc. | 871,2 Mio. $ Mid Cap | 17,02 $ | 8,3 | — | 82 | Details › |
| 122 | LXRX LEXICON PHARMACEUTICALS, INC. | 815,8 Mio. $ Mid Cap | 2,02 $ | — | — | 42 | Details › |
| 123 | HELP CYBIN INC. | 797,7 Mio. $ Mid Cap | 12,77 $ | — | — | 41 | Details › |
| 124 | PHAR Pharming Group N.V. | 760,2 Mio. $ Mid Cap | 11,85 $ | — | — | — | Details › |
| 125 | COLL COLLEGIUM PHARMACEUTICAL, INC | 741,0 Mio. $ Mid Cap | 22,92 $ | 13,5 | — | 68 | Details › |
| 126 | ZVRA ZEVRA THERAPEUTICS, INC. | 720,9 Mio. $ Mid Cap | 12,06 $ | 9,4 | — | 41 | Details › |
| 127 | BBOT BridgeBio Oncology Therapeutics, Inc. | 708,7 Mio. $ Mid Cap | 5,52 $ | — | — | 24 | Details › |
| 128 | ANNX Annexon, Inc. | 697,5 Mio. $ Mid Cap | 4,14 $ | — | — | 50 | Details › |
| 129 | IRWD IRONWOOD PHARMACEUTICALS INC | 680,0 Mio. $ Mid Cap | 3,97 $ | 27,8 | — | 63 | Details › |
| 130 | IXHL Incannex Healthcare Inc. | 655,1 Mio. $ Mid Cap | 3,25 $ | — | — | 32 | Details › |
| 131 | GYRE GYRE THERAPEUTICS, INC. | 654,7 Mio. $ Mid Cap | 6,74 $ | 358,5 | 3,4 % | 43 | Details › |
| 132 | CRMD CorMedix Inc. | 648,4 Mio. $ Mid Cap | 7,96 $ | 4,0 | — | 47 | Details › |
| 133 | OCS Oculis Holding AG | 643,7 Mio. $ Mid Cap | 11,31 $ | — | — | 45 | Details › |
| 134 | AQST Aquestive Therapeutics, Inc. | 635,9 Mio. $ Mid Cap | 4,99 $ | — | — | 21 | Details › |
| 135 | VSTM Verastem, Inc. | 628,1 Mio. $ Mid Cap | 7,62 $ | — | — | 35 | Details › |
| 136 | NVCT Nuvectis Pharma, Inc. | 616,0 Mio. $ Mid Cap | 22,49 $ | — | — | 28 | Details › |
| 137 | EOLS Evolus, Inc. | 577,3 Mio. $ Mid Cap | 7,91 $ | — | — | 58 | Details › |
| 138 | SPRY ARS Pharmaceuticals, Inc. | 535,2 Mio. $ Mid Cap | 5,06 $ | — | — | 36 | Details › |
| 139 | KMDA KAMADA LTD | 462,4 Mio. $ Mid Cap | 7,99 $ | — | 3,1 % | 64 | Details › |
| 140 | AVIR Atea Pharmaceuticals, Inc. | 443,8 Mio. $ Mid Cap | 5,18 $ | — | — | 60 | Details › |
| 141 | PSTV CERENOME, INC. | 429,9 Mio. $ Mid Cap | 3,10 $ | — | — | — | Details › |
| 142 | FENC FENNEC PHARMACEUTICALS INC. | 425,3 Mio. $ Mid Cap | 11,30 $ | — | — | 40 | Details › |
| 143 | ACHV ACHIEVE LIFE SCIENCES, INC. | 417,4 Mio. $ Mid Cap | 7,28 $ | — | — | 25 | Details › |
| 144 | TTRX Turn Therapeutics Inc. | 404,9 Mio. $ Mid Cap | 13,38 $ | — | — | 39 | Details › |
| 145 | IRD Opus Genetics, Inc. | 400,5 Mio. $ Mid Cap | 6,07 $ | — | — | 46 | Details › |
| 146 | RZLT Rezolute, Inc. | 382,8 Mio. $ Mid Cap | 4,17 $ | — | — | 44 | Details › |
| 147 | EYPT EyePoint, Inc. | 377,7 Mio. $ Mid Cap | 4,25 $ | — | — | 43 | Details › |
| 148 | QNRX Quoin Pharmaceuticals Ltd. | 375,0 Mio. $ Mid Cap | 6,90 $ | — | — | 34 | Details › |
| 149 | XFOR X4 Pharmaceuticals, Inc | 319,1 Mio. $ Mid Cap | 3,40 $ | — | — | 45 | Details › |
| 150 | RMTI ROCKWELL MEDICAL, INC. | 317,6 Mio. $ Mid Cap | 8,04 $ | — | — | 43 | Details › |
| 151 | VNDA Vanda Pharmaceuticals Inc. | 315,0 Mio. $ Mid Cap | 5,04 $ | — | — | 53 | Details › |
| 152 | EBS Emergent BioSolutions Inc. | 312,6 Mio. $ Mid Cap | 5,87 $ | 6,5 | — | 70 | Details › |
| 153 | IFRX InflaRx N.V. | 301,2 Mio. $ Mid Cap | 2,05 $ | — | — | 37 | Details › |
| 154 | ELTP ELITE PHARMACEUTICALS INC /NV/ | 279,9 Mio. $ Small Cap | 0,25 $ | 8,7 | — | 65 | Details › |
| 155 | ZNTL Zentalis Pharmaceuticals, Inc. | 278,4 Mio. $ Small Cap | 3,59 $ | — | — | 37 | Details › |
| 156 | MGNX MACROGENICS INC | 273,5 Mio. $ Small Cap | 3,97 $ | — | — | 43 | Details › |
| 157 | AKBA Akebia Therapeutics, Inc. | 273,4 Mio. $ Small Cap | 0,95 $ | — | — | 73 | Details › |
| 158 | ALEC Alector, Inc. | 272,6 Mio. $ Small Cap | 2,14 $ | — | — | 47 | Details › |
| 159 | FULC Fulcrum Therapeutics, Inc. | 254,3 Mio. $ Small Cap | 3,80 $ | — | — | 34 | Details › |
| 160 | ACB AURORA CANNABIS INC | 238,8 Mio. $ Small Cap | 3,94 $ | — | — | — | Details › |
| 161 | TLSI TriSalus Life Sciences, Inc. | 236,5 Mio. $ Small Cap | 4,70 $ | — | — | 62 | Details › |
| 162 | CRDL Cardiol Therapeutics Inc. | 235,7 Mio. $ Small Cap | 1,98 $ | — | — | 42 | Details › |
| 163 | IVVD Invivyd, Inc. | 232,9 Mio. $ Small Cap | 0,78 $ | — | — | 27 | Details › |
| 164 | SIGA SIGA TECHNOLOGIES INC | 229,2 Mio. $ Small Cap | 3,02 $ | 10,0 | 18,8 % | 64 | Details › |
| 165 | GLSI Greenwich LifeSciences, Inc. | 227,3 Mio. $ Small Cap | 15,06 $ | — | — | 21 | Details › |
| 166 | ELDN Eledon Pharmaceuticals, Inc. | 221,0 Mio. $ Small Cap | 2,78 $ | — | — | 53 | Details › |
| 167 | SLGL Sol-Gel Technologies Ltd. | 217,7 Mio. $ Small Cap | 66,79 $ | — | — | — | Details › |
| 168 | PLX Protalix BioTherapeutics, Inc. | 213,1 Mio. $ Small Cap | 2,73 $ | — | — | 64 | Details › |
| 169 | MREO Mereo BioPharma Group plc | 202,9 Mio. $ Small Cap | 0,24 $ | — | — | 65 | Details › |
| 170 | ACOG Alpha Cognition Inc. | 195,8 Mio. $ Small Cap | 9,22 $ | — | — | 48 | Details › |
| 171 | DERM Journey Medical Corp | 195,2 Mio. $ Small Cap | 7,09 $ | — | — | 64 | Details › |
| 172 | NERV Minerva Neurosciences, Inc. | 189,1 Mio. $ Small Cap | 4,16 $ | — | — | 57 | Details › |
| 173 | NGEN NERVGEN PHARMA CORP. | 176,3 Mio. $ Small Cap | 2,17 $ | — | — | 42 | Details › |
| 174 | MDWD MediWound Ltd. | 175,9 Mio. $ Small Cap | 13,71 $ | — | — | 39 | Details › |
| 175 | TNXP Tonix Pharmaceuticals Holding Corp. | 168,3 Mio. $ Small Cap | 12,28 $ | — | — | 45 | Details › |
| 176 | LENZ LENZ Therapeutics, Inc. | 167,1 Mio. $ Small Cap | 4,72 $ | — | — | 24 | Details › |
| 177 | CHRS Coherus Oncology, Inc. | 166,0 Mio. $ Small Cap | 1,34 $ | 1,0 | — | 46 | Details › |
| 178 | ANTX AN2 Therapeutics, Inc. | 163,9 Mio. $ Small Cap | 5,69 $ | — | — | 32 | Details › |
| 179 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | 159,6 Mio. $ Small Cap | 4,09 $ | — | — | 64 | Details › |
| 180 | MENS Jyong Biotech Ltd. | 153,6 Mio. $ Small Cap | 2,00 $ | — | — | — | Details › |
| 181 | BMEA Biomea Fusion, Inc. | 139,5 Mio. $ Small Cap | 1,70 $ | — | — | 40 | Details › |
| 182 | MIST Milestone Pharmaceuticals Inc. | 120,0 Mio. $ Small Cap | 1,05 $ | — | — | 33 | Details › |
| 183 | NRXP NRX Pharmaceuticals, Inc. | 110,1 Mio. $ Small Cap | 3,40 $ | — | — | 27 | Details › |
| 184 | BGM BGM Group Ltd. | 109,2 Mio. $ Small Cap | 0,27 $ | — | — | — | Details › |
| 185 | CNTB Connect Biopharma Holdings Ltd | 107,8 Mio. $ Small Cap | 2,06 $ | — | — | 39 | Details › |
| 186 | JUNS JUPITER NEUROSCIENCES, INC. | 106,1 Mio. $ Small Cap | 3,15 $ | — | — | 2 | Details › |
| 187 | AARD Aardvark Therapeutics, Inc. | 102,3 Mio. $ Small Cap | 5,06 $ | — | — | 67 | Details › |
| 188 | CPIX CUMBERLAND PHARMACEUTICALS INC | 99,0 Mio. $ Small Cap | 6,48 $ | — | — | 65 | Details › |
| 189 | VRCA Verrica Pharmaceuticals Inc. | 90,4 Mio. $ Small Cap | 4,95 $ | — | — | 43 | Details › |
| 190 | ICCC IMMUCELL CORP /DE/ | 89,0 Mio. $ Small Cap | 9,91 $ | — | — | 66 | Details › |
| 191 | VTVT vTv Therapeutics Inc. | 87,3 Mio. $ Small Cap | 31,86 $ | — | — | 38 | Details › |
| 192 | CTOR CITIUS ONCOLOGY, INC. | 77,6 Mio. $ Small Cap | 0,91 $ | — | — | — | Details › |
| 193 | PTHS Pelthos Therapeutics Inc. | 77,3 Mio. $ Small Cap | 21,34 $ | — | — | 14 | Details › |
| 194 | ZYBT Zhengye Biotechnology Holding Ltd | 73,9 Mio. $ Small Cap | 1,59 $ | — | — | — | Details › |
| 195 | ATHE ALTERITY THERAPEUTICS LTD | 72,9 Mio. $ Small Cap | 4,11 $ | — | — | — | Details › |
| 196 | PMVP PMV Pharmaceuticals, Inc. | 71,5 Mio. $ Small Cap | 1,44 $ | — | — | 45 | Details › |
| 197 | SPRO Spero Therapeutics, Inc. | 67,1 Mio. $ Small Cap | 1,12 $ | 7,9 | — | 42 | Details › |
| 198 | ACRV Acrivon Therapeutics, Inc. | 66,5 Mio. $ Small Cap | 2,04 $ | — | — | 50 | Details › |
| 199 | SKYE Skye Bioscience, Inc. | 62,8 Mio. $ Small Cap | 2,08 $ | — | — | 12 | Details › |
| 200 | INCR Intercure Ltd. | 61,8 Mio. $ Small Cap | 5,24 $ | — | — | — | Details › |
| 201 | SGP SpyGlass Pharma, Inc. | 60,8 Mio. $ Small Cap | 27,96 $ | — | — | 20 | Details › |
| 202 | TLPH TALPHERA, INC. | 58,7 Mio. $ Small Cap | 1,24 $ | — | — | 69 | Details › |
| 203 | ATYR aTYR PHARMA INC | 47,1 Mio. $ Micro Cap | 0,43 $ | — | — | 48 | Details › |
| 204 | TELO Telomir Pharmaceuticals, Inc. | 40,9 Mio. $ Micro Cap | 1,18 $ | — | — | — | Details › |
| 205 | CLNN Clene Inc. | 39,3 Mio. $ Micro Cap | 3,65 $ | — | — | 42 | Details › |
| 206 | ATNM Actinium Pharmaceuticals, Inc. | 38,4 Mio. $ Micro Cap | 1,31 $ | — | — | — | Details › |
| 207 | SCLX Scilex Holding Co | 37,8 Mio. $ Micro Cap | 5,05 $ | — | — | 54 | Details › |
| 208 | KAPA Kairos Pharma, LTD. | 36,9 Mio. $ Micro Cap | 1,68 $ | — | — | 26 | Details › |
| 209 | CNTX Context Therapeutics Inc. | 34,6 Mio. $ Micro Cap | 0,37 $ | — | — | 57 | Details › |
| 210 | OTLK Outlook Therapeutics, Inc. | 34,5 Mio. $ Micro Cap | 0,66 $ | — | — | 7 | Details › |
| 211 | EDSA Edesa Biotech, Inc. | 33,8 Mio. $ Micro Cap | 4,66 $ | — | — | 55 | Details › |
| 212 | KYNB KYNTRA BIO, INC. | 33,3 Mio. $ Micro Cap | 7,98 $ | 0,2 | — | 49 | Details › |
| 213 | MIRA MIRA PHARMACEUTICALS, INC. | 32,5 Mio. $ Micro Cap | 0,79 $ | — | — | — | Details › |
| 214 | KPTI Karyopharm Therapeutics Inc. | 31,5 Mio. $ Micro Cap | 1,62 $ | — | — | 18 | Details › |
| 215 | ASBP Aspire Biopharma Holdings, Inc. | 31,3 Mio. $ Micro Cap | 9,12 $ | — | — | 46 | Details › |
| 216 | ELAB PMGC Holdings Inc. | 29,8 Mio. $ Micro Cap | 4,60 $ | — | — | 41 | Details › |
| 217 | APUS Apimeds Pharmaceuticals US, Inc. | 28,9 Mio. $ Micro Cap | 2,17 $ | — | — | — | Details › |
| 218 | ABVC ABVC BIOPHARMA, INC. | 26,6 Mio. $ Micro Cap | 0,98 $ | — | — | — | Details › |
| 219 | TXMD TherapeuticsMD, Inc. | 25,6 Mio. $ Micro Cap | 2,12 $ | — | — | — | Details › |
| 220 | IGC IGC Pharma, Inc. | 23,4 Mio. $ Micro Cap | 0,28 $ | — | — | 49 | Details › |
| 221 | RNTX Rein Therapeutics, Inc. | 22,8 Mio. $ Micro Cap | 0,78 $ | — | — | 24 | Details › |
| 222 | GRCE Grace Therapeutics, Inc. | 20,1 Mio. $ Micro Cap | 2,26 $ | — | — | 31 | Details › |
| 223 | AYTU AYTU BIOPHARMA, INC | 19,8 Mio. $ Micro Cap | 2,05 $ | — | — | — | Details › |
| 224 | TENX TENAX THERAPEUTICS, INC. | 18,4 Mio. $ Micro Cap | 1,95 $ | — | — | 26 | Details › |
| 225 | BFRI Biofrontera Inc. | 18,2 Mio. $ Micro Cap | 1,46 $ | — | — | 43 | Details › |
| 226 | NNVC NANOVIRICIDES, INC. | 17,9 Mio. $ Micro Cap | 1,02 $ | — | — | 58 | Details › |
| 227 | CYCN Korsana Biosciences, Inc. | 16,2 Mio. $ Micro Cap | 23,52 $ | — | — | 35 | Details › |
| 228 | PPCB Propanc Biopharma, Inc. | 14,1 Mio. $ Micro Cap | 1,21 $ | — | — | — | Details › |
| 229 | CPHI CHINA PHARMA HOLDINGS, INC. | 13,1 Mio. $ Micro Cap | 0,76 $ | — | — | 49 | Details › |
| 230 | PHIO Phio Pharmaceuticals Corp. | 12,0 Mio. $ Micro Cap | 1,01 $ | — | — | 28 | Details › |
| 231 | COSM Cosmos Health Inc. | 11,1 Mio. $ Micro Cap | 0,25 $ | — | — | 38 | Details › |
| 232 | BLRX BioLineRx Ltd. | 11,0 Mio. $ Micro Cap | 2,67 $ | — | — | — | Details › |
| 233 | CTXR Citius Pharmaceuticals, Inc. | 10,8 Mio. $ Micro Cap | 0,59 $ | — | 103,1 % | 33 | Details › |
| 234 | HOTH Rocket One Inc. | 10,7 Mio. $ Micro Cap | 0,69 $ | — | — | 22 | Details › |
| 235 | CLRB Cellectar Biosciences, Inc. | 10,2 Mio. $ Micro Cap | 2,37 $ | — | — | — | Details › |
| 236 | ADIL ADIAL PHARMACEUTICALS, INC. | 7,4 Mio. $ Micro Cap | 6,00 $ | — | — | 5 | Details › |
| 237 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | 7,2 Mio. $ Micro Cap | 3,53 $ | — | — | — | Details › |
| 238 | MGRX MANGOCEUTICALS, INC. | 6,5 Mio. $ Micro Cap | 0,39 $ | — | — | 17 | Details › |
| 239 | JAGX Jaguar Health, Inc. | 5,8 Mio. $ Micro Cap | 0,32 $ | — | — | — | Details › |
| 240 | BFRG BullFrog AI Holdings, Inc. | 5,5 Mio. $ Micro Cap | 0,49 $ | — | — | — | Details › |
| 241 | TPST Tempest Therapeutics, Inc. | 4,9 Mio. $ Micro Cap | 0,80 $ | — | — | 27 | Details › |
| 242 | LABT Lakewood-Amedex Biotherapeutics Inc. | 3,8 Mio. $ Micro Cap | 2,05 $ | — | — | — | Details › |
| 243 | AIXC AIxCrypto Holdings, Inc. | 3,7 Mio. $ Micro Cap | 0,74 $ | — | — | 35 | Details › |
| 244 | CNSP CNS Pharmaceuticals, Inc. | 3,6 Mio. $ Micro Cap | 5,75 $ | — | — | — | Details › |
| 245 | ACXP Acurx Pharmaceuticals, Inc. | 3,4 Mio. $ Micro Cap | 1,40 $ | — | — | 44 | Details › |
| 246 | RADX Radiopharm Theranostics Ltd | 2,9 Mio. $ Micro Cap | 2,05 $ | — | — | — | Details › |
| 247 | AEON AEON Biopharma, Inc. | 2,8 Mio. $ Micro Cap | 0,29 $ | — | — | 16 | Details › |
| 248 | CVKD Cadrenal Therapeutics, Inc. | 2,8 Mio. $ Micro Cap | 1,18 $ | — | 1.375,0 % | 38 | Details › |
| 249 | UPC Universe Pharmaceuticals INC | 2,6 Mio. $ Micro Cap | 3,88 $ | — | — | — | Details › |
| 250 | SNOA Sonoma Pharmaceuticals, Inc. | 2,4 Mio. $ Micro Cap | 1,31 $ | — | — | — | Details › |
| 251 | ATPC Agape ATP Corp | 2,3 Mio. $ Micro Cap | 2,37 $ | — | — | — | Details › |
| 252 | ENSC Ensysce Biosciences, Inc. | 2,2 Mio. $ Micro Cap | 0,52 $ | — | — | 8 | Details › |
| 253 | RDHL RedHill Biopharma Ltd. | 2,1 Mio. $ Micro Cap | 0,72 $ | — | — | — | Details › |
| 254 | ENVB Enveric Biosciences, Inc. | 1,5 Mio. $ Micro Cap | 1,46 $ | — | — | — | Details › |
| 255 | CMND Clearmind Medicine Inc. | 1,5 Mio. $ Micro Cap | 0,98 $ | — | — | — | Details › |
| 256 | ONCO Onconetix, Inc. | 1,3 Mio. $ Micro Cap | 0,78 $ | — | 151,3 % | — | Details › |
| 257 | IMCC IM Cannabis Corp. | 1,3 Mio. $ Micro Cap | 0,12 $ | — | — | — | Details › |
| 258 | MTNB Matinas BioPharma Holdings, Inc. | 1,2 Mio. $ Micro Cap | 0,21 $ | — | — | 13 | Details › |
| 259 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | 1,1 Mio. $ Micro Cap | 0,93 $ | — | — | — | Details › |
| 260 | SXTC China SXT Pharmaceuticals, Inc. | 1,0 Mio. $ Micro Cap | 1,93 $ | — | — | — | Details › |
| 261 | AIM AIM ImmunoTech Inc. | 705.150 $ Micro Cap | 0,23 $ | — | — | 21 | Details › |
| 262 | SBEV Endovia Health Sciences, Inc. | 517.315 $ Micro Cap | 0,31 $ | — | — | — | Details › |
| 263 | TIVC Valion Bio, Inc. | 419.279 $ Micro Cap | 0,17 $ | — | — | — | Details › |
| 264 | PBM PSYENCE BIOMEDICAL LTD. | 94.524 $ Micro Cap | 4,33 $ | — | — | — | Details › |
| 265 | PRFX PRF Technologies Ltd. | 74.516 $ Micro Cap | 0,99 $ | — | — | — | Details › |